PG vs XXII

Procter & Gamble (PG) remains a fundamentally strong consumer staples company, boasting exceptional financial health, consistent profitability, and a robust dividend history. The recent Q3 2026 earnings beat and return to volume growth are positive indicators of operational stability and market execution. However, for a mega-cap company of P&G's scale operating in mature, saturated markets, these ...

22nd Century Group Inc. (XXII) remains an extremely high-risk investment with virtually no clear path to 10x growth for common shareholders in its current state. The company continues to face dire financial health, as evidenced by Q1 2026 results reporting declining revenue (-31.1% YoY), a negative gross loss ($0.636M), and significant net ($3.019M) and operating ($3.039M) losses. Its cash positio...